Wird geladen...
Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that accumulate during pathologic conditions, such as cancer. Patients diagnosed with advanced metastatic cancers have an average survival of 12–24 mo, a survival time that hasn't changed significa...
Gespeichert in:
| Veröffentlicht in: | J Leukoc Biol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Society for Leukocyte Biology
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608049/ https://ncbi.nlm.nih.gov/pubmed/28546500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5VMR1116-458RRR |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|